Octave Group logo

Octave Group

North America, New York, United States, New York

Description

Octave Group believe in the power of music and media to inspire emotional connections in shared spaces

Investor Profile

Octave Group has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Machine Learning
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Octave Group frequently co-invest with?

MSD Partners
North America, New York, United States, New York
Co-Investments: 1
Susquehanna International Group (SIG)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 1
Shumway Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Co-Investments: 1
MSD Capital
North America, New York, United States, New York
Co-Investments: 1
Avenir
North America, New York, United States, New York
Co-Investments: 1
OCV
North America, California, United States, Los Angeles
Co-Investments: 1
OMX Ventures
North America, Illinois, United States, Lincolnshire
Co-Investments: 1
Humboldt Fund
North America, New York, United States, New York
Co-Investments: 1
Octave Ventures LLC
North America, Nevada, United States, Henderson
Co-Investments: 1

What are some of recent deals done by Octave Group?

Finch Therapeutics

Somerville, Massachusetts, United States

Finch Therapeutics is a microbiome development company that serve patients with serious unmet medical needs.

BiotechnologyClinical TrialsMachine LearningTherapeutics
Series DSep 17, 2020
Amount Raised: $90,000,000